Arkolith/Insider Trading/HRTX/Form 4

Forbes William P

EVP, Chief Development OfficerHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Nov 21, 2023
Net Buying
Open-Market Buys
$27K
Open-Market Sells
$0
Net Open-Market Flow
$27K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2023Buy(P)25K$1.09$27K79K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056198) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML